Over 1050 Total Lots Up For Auction at Two Locations - NJ 08/01, CA 08/09

Cecilia Danckwardt-Lillieström

C-RAD appoints new CFO
August 28, 2018
Rad Oncology Radiation Therapy
C-RAD today announces that Cecilia Danckwardt-Lillieström has been appointed Chief Financial Officer effective October 15, 2018, succeeding Therése Björklund who will assume another position within the finance department at the company.

Cecilia has an extensive experience and has held several leading positions within finance. She is currently a Senior Manager & Head of the Uppsala office for the financial audit and consulting firm KPMG, a position she has held for 3 years. Prior to that, she held the position as CFO for Fastum UBC Förvaltning AB. She has also worked for RaySearch Laboratories AB as CFO, as Director of Finance for MySQL AB, for Biotage AB (publ) as Group controller and for PwC as Senior Manager. Cecilia holds a master’s degree in business and Economics from the Uppsala University.

Therése decided to step down from the position as CFO for personal reasons.

“Cecilia´s very broad financial experience will be a great asset for C-RAD supporting the growing organization. I am very much looking forward to work with Cecilia as our CFO and I am confident that she will be a strong addition to the management team of C-RAD.” says Tim Thurn, CEO C-RAD AB

“I am really looking forward to join the management team of C-RAD. I will certainly do my best to contribute in the continuing development of the finance strategy as well as the future growth of C-RAD”, says Cecilia Danckwardt-Lillieström.

“I want to take the opportunity to thank Therése for the excellent work and the support during the past two years. As a member of the management team she has made an important contribution to build up the organization and finance department in a period a significant growth. I very much welcome her decision to stay in the organization after her change.” says Tim Thurn, CEO C-RAD AB.


About C-RAD
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.

You Must Be Logged In To Post A Comment

 

advertisement

Rad Oncology Homepage

Study finds ROCR oncology reimbursement model cuts Medicare spending by 3%
May represent a step toward prioritizing value over volume
GE HealthCare’s MIM Software introduces MR-guided prostate brachytherapy
Symphony HDR Prostate supports live ultrasound procedures
Regional Missouri hospital gets $15 million for new cancer center
Hannibal Regional received the funds as part of the governor's state budget
When do the superior outcomes from proton therapy justify the costs?
Unpacking the evolving state of proton therapy coverage and demonstrated benefits
RadMachine: Elevating Diagnostic QC from Spreadsheets to Cloud-Based Efficiency
In the fast-paced world of diagnostic imaging and nuclear medicine, maintaining rigorous quality control standards is essential for ensuring accurate diagnoses and patient safety. RadMachine, a comprehensive cloud-based QC platform, stands at the forefront - pushing the boundaries of efficiency and accuracy beyond traditional spreadsheets and other manual tracking methods.
Hitachi's new image-guided radiotherapy system debuts with RaySearch IT
First clinical treatment with OXRAY system performed in Japan
Mayo Clinic taps Cosylab for carbon ion radiotherapy software
The facility, with Hitachi gantry, is expected to open early next year
Proton therapy yields better quality of life than radiotherapy for head and neck cancer: Study
Reducing malnutrition and feeding-tube dependency with comparable survival rate
Bipartisan bill seeks to revamp Medicare's radiation oncology payments
A step toward episode-based payments and away from fee-for-service
Elekta acquires Philips radiotherapy portfolio
Will incorporate Pinnacle treatment planning into Elekta ONE software suite